TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 27919284

Group type: EXPERIMENTAL
Intervention: U-MDT
Number of subjects: 753

Group type: COMPARATOR
Intervention: Regular MDT (R-MDT)
Number of subjects: 753

Group type: EXPERIMENTAL
Intervention: ML Flow test positivity
Number of subjects: 753

Group type: EXPERIMENTAL
Intervention: MB patients with high BI
Number of subjects: 753

Group type: EXPERIMENTAL
Intervention: Negative BI
Number of subjects: 753
Study: 24747100

Group type: EXPERIMENTAL
Intervention: ICD therapy episodes for life-threatening VA
Number of subjects: 811

Group type: EXPERIMENTAL
Intervention: ICD therapy episodes for life-threatening VA in patients not on beta-blocker therapy
Number of subjects: 811
Study: 22689866

Group type: EXPERIMENTAL
Intervention: Cycled lighting (CL)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Dim lighting (DL)
Number of subjects: 37
Study: 20518617

Group type: EXPERIMENTAL
Intervention: Perindopril/indapamide fixed-dose combination
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intensive glucose lowering with gliclazide modified release (MR)
Number of subjects: 0
Study: 17651153

Group type: EXPERIMENTAL
Intervention: IgE reactivity to Ara h2 before DBPCFC
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: IgE reactivity to Ara h6 before DBPCFC
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: IgE reactivity to Ara h1 and Ara h3 before DBPCFC
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Peanut-specific IgE levels before and after DBPCFC
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Skin prick tests (SPTs) with Ara h2 and Ara h6
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Skin prick tests (SPTs) with Ara h1 and Ara h3
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Weal size induced by Ara h6
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Relationship of parameters to severity of peanut allergy
Number of subjects: 20
Study: 15985013

Group type: EXPERIMENTAL
Intervention: Cycled IL-2 plus antiretroviral therapy (ART)
Number of subjects: 54

Group type: COMPARATOR
Intervention: ART alone
Number of subjects: 54
Study: 12921577

Group type: EXPERIMENTAL
Intervention: TACE plus HIFU (T + H)
Number of subjects: 50

Group type: COMPARATOR
Intervention: TACE (T)
Number of subjects: 50
Study: 10646049

Group type: EXPERIMENTAL
Intervention: Racecadotril (1.5 mg/kg three times daily)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Loperamide (0.03 mg/kg three times daily)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Racecadotril
Number of subjects: 102

Group type: COMPARATOR
Intervention: Loperamide
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Racecadotril and Loperamide
Number of subjects: 102
Study: 8660080

Group type: EXPERIMENTAL
Intervention: Lymphoblastoid interferon alfa (3 million units/m2) for 12 months
Number of subjects: 21

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 21
Study: 1804731

Group type: EXPERIMENTAL
Intervention: Stress management programme (six 40-min sessions with a physiotherapist)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Conventional therapy (including antispasmodic Colpermin)
Number of subjects: 35
Study: 6683632

Group type: EXPERIMENTAL
Intervention: Adriamycin-cyclophosphamide (6 courses)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Adriamycin-cyclophosphamide (6 courses) + Levamisole (immunotherapy for 2 years)
Number of subjects: 52
Study: 30535333

Group type: EXPERIMENTAL
Intervention: Peroxidized oils (all oil sources)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Peroxidized oils
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Peroxidized palm oil
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Peroxidized soybean oil
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Oil source (various oils)
Number of subjects: 200
Study: 30390713

Group type: EXPERIMENTAL
Intervention: Disruptive Behavior International Scale - Nepal version (DBIS-N)
Number of subjects: 268

Group type: COMPARATOR
Intervention: Eyberg Child Behavior Inventory (ECBI)
Number of subjects: 268
Study: 27456494

Group type: EXPERIMENTAL
Intervention: Prebiotics (oligofructose-enriched inulin 8 g orally/day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (maltodextrin 3.3 g orally/day)
Number of subjects: 0
Study: 24818207

Group type: EXPERIMENTAL
Intervention: Curved titanium abutment
Number of subjects: 26

Group type: COMPARATOR
Intervention: Conventional titanium abutment (control)
Number of subjects: 26
Study: 23119078

Group type: EXPERIMENTAL
Intervention: Alcohol beverage
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 20963579

Group type: EXPERIMENTAL
Intervention: Transcranial Magnetic Stimulation (TMS) over left ventral premotor cortex (L-PMv)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Transcranial Magnetic Stimulation (TMS) over left dorsal premotor cortex (L-PMd)
Number of subjects: 0
Study: 17331650

Group type: EXPERIMENTAL
Intervention: Xenogenic acellular dermal matrix (Group A)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Porcine acellular dermal matrix (Group C)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Betadine ointment gauzes (Group B)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Betadine ointment gauzes (Group D)
Number of subjects: 72
Study: 16279563

Group type: EXPERIMENTAL
Intervention: Food elimination diet based on skin prick and atopy patch testing results
Number of subjects: 146
Study: 12350056

Group type: EXPERIMENTAL
Intervention: 0.75% metronidazole vaginal gel
Number of subjects: 145

Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 145
Study: 10195720

Group type: EXPERIMENTAL
Intervention: Laparoscopic Nissen fundoplication (LNF)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Open Nissen fundoplication (ONF)
Number of subjects: 42
Study: 7786565

Group type: EXPERIMENTAL
Intervention: Explanatory letter sent before telephone contact
Number of subjects: 2000

Group type: COMPARATOR
Intervention: No explanatory letter sent before telephone contact
Number of subjects: 2000
Study: 2195066

Group type: EXPERIMENTAL
Intervention: Educational home visits by pharmacists
Number of subjects: 284

Group type: COMPARATOR
Intervention: Control group (no educational home visits)
Number of subjects: 284
Study: 475943

Group type: EXPERIMENTAL
Intervention: Bupropion 50 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Bupropion 100 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Amitriptyline 25 mg (base)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Dexamphetamine 10 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Dexamphetamine 5 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Amitriptyline
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Bupropion
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Dexamphetamine
Number of subjects: 12
Study: 31403935

Group type: EXPERIMENTAL
Intervention: Physical activity practice from childhood to adolescence
Number of subjects: 870

Group type: COMPARATOR
Intervention: No physical activity practice from childhood to adolescence
Number of subjects: 870
Study: 31094803

Group type: EXPERIMENTAL
Intervention: 8-mg dexamethasone
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 25955722

Group type: EXPERIMENTAL
Intervention: Intradialytic aerobic cycling training (30 min, 55%-60% peak power, 3 days/week) for 3 months
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 18
Study: 23097216

Group type: EXPERIMENTAL
Intervention: SRP + 0.5% CLM (test; group 1)
Number of subjects: 98

Group type: COMPARATOR
Intervention: SRP + placebo (control; group 2)
Number of subjects: 98
Study: 22574814

Group type: EXPERIMENTAL
Intervention: EMLA® (n=20)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo cream (n=19)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Comparison between EMLA® and placebo
Number of subjects: 39
Study: 19713257

Group type: EXPERIMENTAL
Intervention: Gabapentin (3 x 400 mg)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Phenytoin (3 x 100 mg)
Number of subjects: 80
Study: 16876433

Group type: EXPERIMENTAL
Intervention: Implicit motor learning
Number of subjects: 0

Group type: COMPARATOR
Intervention: Explicit motor learning
Number of subjects: 0
Study: 15553661

Group type: EXPERIMENTAL
Intervention: Candesartan cilexetil 8 mg
Number of subjects: 1967

Group type: EXPERIMENTAL
Intervention: Candesartan cilexetil 16 mg
Number of subjects: 1967
Study: 12394224

Group type: EXPERIMENTAL
Intervention: Ranitidine bismuth citrate (RBC) 400 mg B.I.D., clarithromycin (C) 500 mg B.I.D., metronidazole (M) 500 mg every morning and 1,000 mg every evening for 14 days
Number of subjects: 26

Group type: COMPARATOR
Intervention: Previous treatment with omeprazole (O) 20 mg, clarithromycin (C) 250 mg, metronidazole (M) 500 mg
Number of subjects: 26

Group type: COMPARATOR
Intervention: Previous treatment with ranitidine bismuth citrate (RBC) 400 mg, tetracycline (T) 1,000 mg, metronidazole (M) 500 mg
Number of subjects: 26
Study: 9917784

Group type: EXPERIMENTAL
Intervention: Subconjunctival mitomycin C (0.25 ml of 0.2 mg/ml)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Untreated eyes
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Subconjunctival mitomycin C
Number of subjects: 9
Study: 8772214

Group type: EXPERIMENTAL
Intervention: Adjusted-dose oral anticoagulants (OAC) - acenocoumarol, target INR 2.0-3.0
Number of subjects: 672

Group type: COMPARATOR
Intervention: Fixed-dose subcutaneous low molecular weight heparin (LMWH) - nadroparine, 60 aXa IU/kg once daily
Number of subjects: 672

Group type: EXPERIMENTAL
Intervention: Adjusted-dose oral anticoagulants (OAC)
Number of subjects: 672

Group type: COMPARATOR
Intervention: Fixed-dose subcutaneous low molecular weight heparin (LMWH) - nadroparine
Number of subjects: 672
Study: 2206004

Group type: EXPERIMENTAL
Intervention: Growth hormone (GH) treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 7302997

Group type: EXPERIMENTAL
Intervention: Chemoimmunotherapy with Krestin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Chemotherapy
Number of subjects: 0
Study: 31267794

Group type: EXPERIMENTAL
Intervention: Graphic Health Warnings (GHWs)
Number of subjects: 244

Group type: COMPARATOR
Intervention: Text-only cigarette pack
Number of subjects: 244
Study: 27405902

Group type: EXPERIMENTAL
Intervention: All-around nursing care
Number of subjects: 98

Group type: COMPARATOR
Intervention: General nursing care
Number of subjects: 98
Study: 28880416

Group type: EXPERIMENTAL
Intervention: Hot application
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Cold application
Number of subjects: 96

Group type: COMPARATOR
Intervention: Standard osteoarthritis treatment (Control)
Number of subjects: 96
Study: 27690505

Group type: EXPERIMENTAL
Intervention: Daily (25 mg) plus targeted (25 mg) naltrexone
Number of subjects: 127

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 127
Study: 24419808

Group type: EXPERIMENTAL
Intervention: Bioresorbable vascular scaffolds (BVS)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control group (metallic stent)
Number of subjects: 41
Study: 22959714

Group type: EXPERIMENTAL
Intervention: Everolimus-eluting stents (EESs)
Number of subjects: 2774

Group type: COMPARATOR
Intervention: Sirolimus-eluting stents (SESs)
Number of subjects: 2774
Study: 19734765

Group type: EXPERIMENTAL
Intervention: Radial optic neurotomy (RON)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Cannulation of tissue plasminogen activator (tPA)
Number of subjects: 22
Study: 17522511

Group type: EXPERIMENTAL
Intervention: Multimodal management protocol (intravenous fluid restriction, unrestricted oral intake with prokinetic agents, early ambulation, fixed regimen epidural analgesia)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group (intravenous fluids to prevent oliguria, restricted oral intake until return of bowel motility, weaning regimen epidural analgesia)
Number of subjects: 70
Study: 15199352

Group type: EXPERIMENTAL
Intervention: Pharmacologic treatment for hyperlipidemia
Number of subjects: 4451

Group type: EXPERIMENTAL
Intervention: Maintaining an ideal weight
Number of subjects: 4451

Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 4451

Group type: COMPARATOR
Intervention: Weight > or = 25 kg/m2
Number of subjects: 4451

Group type: COMPARATOR
Intervention: Weight gain
Number of subjects: 4451

Group type: COMPARATOR
Intervention: Becoming inactive
Number of subjects: 4451

Group type: COMPARATOR
Intervention: Older age
Number of subjects: 4451

Group type: COMPARATOR
Intervention: Alcohol consumption
Number of subjects: 4451

Group type: COMPARATOR
Intervention: Treatment for hyperlipidemia
Number of subjects: 4451
Study: 11578723

Group type: COMPARATOR
Intervention: Lim-XRT (Pelvic irradiation): 50 Gy in 25 fractions over 5 weeks
Number of subjects: 484

Group type: EXPERIMENTAL
Intervention: Ext-XRT (Extended irradiation): 50 Gy in pelvis + 25 Gy to para-aortic nodes and liver in 19 fractions over 25 days
Number of subjects: 484
Study: 11225452

Group type: EXPERIMENTAL
Intervention: Laparoscopic cholecystectomy
Number of subjects: 15

Group type: COMPARATOR
Intervention: Conventional cholecystectomy
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Quality of life scores
Number of subjects: 15
Study: 9143575

Group type: EXPERIMENTAL
Intervention: Total gastrectomy
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Total gastrectomy with gastric substitute
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Subtotal gastrectomy
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 75
Study: 7955286

Group type: COMPARATOR
Intervention: Right atrial approach (group B)
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Right ventricular approach (group A)
Number of subjects: 107
Study: 3579683

Group type: EXPERIMENTAL
Intervention: Conventional speech therapy provided by professional speech pathologists twice weekly
Number of subjects: 60

Group type: COMPARATOR
Intervention: Emotionally supportive counseling therapy provided by professional speech pathologists at the same intervals
Number of subjects: 60
Study: 1760712

Group type: EXPERIMENTAL
Intervention: Compounded mixture
Number of subjects: 142

Group type: COMPARATOR
Intervention: Conventional technique with separate bottles
Number of subjects: 142
Study: 786317

Group type: EXPERIMENTAL
Intervention: mineralocorticoid
Number of subjects: 13

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: sympathomimetic drug
Number of subjects: 13
Study: 31820339

Group type: EXPERIMENTAL
Intervention: PF-05280586
Number of subjects: 394

Group type: COMPARATOR
Intervention: Rituximab-EU
Number of subjects: 394
Study: 30527440

Group type: EXPERIMENTAL
Intervention: Nepafenac 0.3%
Number of subjects: 181

Group type: COMPARATOR
Intervention: Ketorolac 0.5%
Number of subjects: 181
Study: 28668914

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (0.1-0.7 μg/kg per hour, titrated by patient-triggered doses of 0.25 μg/kg)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 37

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 37
Study: 27684818

Group type: EXPERIMENTAL
Intervention: Low-dose CT with iterative model reconstruction (IMR)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Low-dose CT with hybrid iterative reconstruction (HIR)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Low-dose CT with filtered back projection (FBP)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Routine-dose CT with filtered back projection (FBP)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Low-dose CT
Number of subjects: 60
Study: 24439687

Group type: EXPERIMENTAL
Intervention: Psychosomatic day hospital treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Waiting time before admission (control condition)
Number of subjects: 0
Study: 22498844

Group type: EXPERIMENTAL
Intervention: Condensed protocol (educational brochure)
Number of subjects: 280

Group type: COMPARATOR
Intervention: Extended protocol (in-person education session)
Number of subjects: 280
Study: 19197129

Group type: EXPERIMENTAL
Intervention: Remifentanil and propofol administered by TCI (blood concentration: 3-5 microg/L for remifentanil and 3-5 mg/L for propofol)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Fentanyl and propofol administered by TCI (fentanyl infusion: 2-3 microg/(kg.h), same propofol concentration as Group R)
Number of subjects: 80
Study: 17496586

Group type: EXPERIMENTAL
Intervention: Topical application of completely autologous platelet gel
Number of subjects: 111

Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 111
Study: 15216550

Group type: EXPERIMENTAL
Intervention: Routine clinical diagnosis plus genetic testing (mutation searching in probands and direct gene testing in relatives)
Number of subjects: 341

Group type: COMPARATOR
Intervention: Routine clinical diagnosis
Number of subjects: 341
Study: 11913682

Group type: EXPERIMENTAL
Intervention: Postoperative application of estriol ointment (n = 14)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Postoperative application of dexpanthenol ointment (n = 12)
Number of subjects: 26
Study: 9702623

Group type: EXPERIMENTAL
Intervention: Rocuronium
Number of subjects: 60

Group type: COMPARATOR
Intervention: Vecuronium
Number of subjects: 60
Study: 7796767

Group type: EXPERIMENTAL
Intervention: Purified Vi polysaccharide vaccine (Typhim Vi), single intramuscular injection.
Number of subjects: 435
Study: 2142081

Group type: EXPERIMENTAL
Intervention: Captopril 25 mg tid
Number of subjects: 90

Group type: COMPARATOR
Intervention: Frusemide 40 mg daily
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study: 624819

Group type: EXPERIMENTAL
Intervention: Colestipol hydrochloride (Colestid)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 31344339

Group type: EXPERIMENTAL
Intervention: Iodine tampon
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control (wound closure and rinsing with Monoject syringe)
Number of subjects: 54
Study: 28034579

Group type: EXPERIMENTAL
Intervention: Telephone-based self-regulation intervention (6 sessions)
Number of subjects: 422
Study: 25682378

Group type: EXPERIMENTAL
Intervention: Informational video about IBIs
Number of subjects: 128

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 128
Study: 24065421

Group type: EXPERIMENTAL
Intervention: Cardiac rehabilitation and exercise (CRE)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 44
Study: 21249382

Group type: EXPERIMENTAL
Intervention: Highly fit adolescent football players (peak VO(2) 43.5 ± 3.4 ml kg(‐1) min(‐1))
Number of subjects: 22

Group type: COMPARATOR
Intervention: Untrained girls (peak VO(2) 36.0 ± 5.1 ml kg(‐1) min(‐1))
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Both groups during acute bout of exercise
Number of subjects: 22
Study: 19963157

Group type: EXPERIMENTAL
Intervention: 20 mL apple cider vinegar, 40 mL water
Number of subjects: 5

Group type: COMPARATOR
Intervention: 60 mL water (placebo)
Number of subjects: 5
Study: 17498850

Group type: EXPERIMENTAL
Intervention: Protein-rich supplementation
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Protein-rich supplementation + Nandrolone decanoate
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 60
Study: 15017784

Group type: EXPERIMENTAL
Intervention: Beraprost sodium 40 micrograms
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Beraprost sodium
Number of subjects: 20
Study: 12215193

Group type: EXPERIMENTAL
Intervention: Early statin therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (no early statin therapy)
Number of subjects: 0
Study: 11477862

Group type: EXPERIMENTAL
Intervention: Sini Decoction (SND)
Number of subjects: 40
Study: 8570063

Group type: EXPERIMENTAL
Intervention: Cefotiam (single dose)
Number of subjects: 129

Group type: COMPARATOR
Intervention: Control (no cefotiam)
Number of subjects: 129
Study: 2773842

Group type: EXPERIMENTAL
Intervention: Intramuscular or oral administration of iron
Number of subjects: 191

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 191
Study: 790551

Group type: EXPERIMENTAL
Intervention: Ketoprofen 100 mg daily
Number of subjects: 10

Group type: COMPARATOR
Intervention: Acetylsalicylic acid 3 g daily
Number of subjects: 10
Study: 30520201

Group type: EXPERIMENTAL
Intervention: Glucose peak > 30 minutes
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: 1 hour ≥ 155 mg/dL
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Monophasic curve
Number of subjects: 93
Study: 29392814

Group type: EXPERIMENTAL
Intervention: In-person patient interview and follow-up telephone interview 3-5 months after discharge
Number of subjects: 1129

Group type: EXPERIMENTAL
Intervention: Assessment from a key hospital worker
Number of subjects: 1129
Study: 27059593

Group type: EXPERIMENTAL
Intervention: Respecting Choices program (intervention)
Number of subjects: 1360

Group type: COMPARATOR
Intervention: Care as usual (control)
Number of subjects: 1360
Study: 25030621

Group type: EXPERIMENTAL
Intervention: Point-of-care C-reactive protein test
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Training in communication skills and use of an interactive patient booklet
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Enhanced communication skills of GP
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Near-patient test as an additional investigation
Number of subjects: 62
Study: 22929469

Group type: EXPERIMENTAL
Intervention: Medical management consisting of intravenous fluids, prophylactic antibiotics, blood transfusions, anti-diarrheals, analgesics, and nutrition
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (no specific control intervention mentioned)
Number of subjects: 48
Study: 20334973

Group type: EXPERIMENTAL
Intervention: High-Risk Experimental (monthly urine screens, compliance checklists, individual and group motivational counseling)
Number of subjects: 42

Group type: COMPARATOR
Intervention: High-Risk Control (standard control)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Low-Risk Control
Number of subjects: 42
Study: 17666462

Group type: EXPERIMENTAL
Intervention: Pioglitazone
Number of subjects: 5238

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5238